2015. ISPOR European Congress – Cost per Patient with Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavarin in Genotype 1 Patients With Chronic HCV in the Netherlands

Gaultney J, de Knegt J, Fassler P, Visser S, Johnson S. Cost per Patient with Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavarin in Genotype 1 Patients With Chronic HCV in the Netherlands. Value Health. 2015 Nov;18(7):A586. Presented at: ISPOR 18th Annual European Congress; November 10, 2015; Milan, Italy.